BU-NOT-SET

CONTACT US
Guidance for start-ups on drug development
  • Drug product
Eyes
Insight
Drug development for start-ups
  • Drug product
  • Drug substance
Test tubes
White paper
Optimising environmental sustainability
  • Sustainability
Eyes
Insight
Adapting to deal with the COVID-19 pandemic
  • Industry trends
Eyes
Insight
On Drug Delivery – Sustainability Q&A
  • Sustainability
Eyes
Insight
Optimising analytical chemistry to improve speed to market
  • Analytical chemistry
Man lab
Insight
The Recipharm Journey
  • Corporate
Eyes
Insight
Solubility enhancement
  • Drug substance
Man holding liquid container
Fact sheet
Unlocking the key changes to Annex 1
  • Manufacturing
Eyes
Insight
Insight
  • Industry trends
COVID-19: a year of unprecedented change
Insight
  • Drug product
Oral solids: market and technology trends
Fact sheet
  • Drug product
Oral modified release
Fact sheet
  • Drug product
Semi-solids an overview of current regulatory requirement
Insight
  • Drug substance
API relocation strategies for CDMO’s
Fact sheet
  • Drug product
  • Manufacturing
Clinical trial material
Insight
  • Drug substance
Time and cost-effective solubility improvement
Insight
  • Drug product
Dosage form development trends and technologies
Insight
  • Drug product
  • Manufacturing
Vaccine Development and Manufacturing